Identification of potential microRNAs regulating metabolic plasticity and cellular phenotypes in glioblastoma

Rupa Bhowmick1,2, Ram Rup Sarkar3,4

  • 1Chemical Engineering and Process Development Division, CSIR-National Chemical Laboratory, Pune, Maharashtra, 411008, India.

Insights

This study identifies key microRNAs (miRNAs) that regulate metabolism and oncogenic phenotypes in glioblastoma. Findings offer potential miRNA combinations for targeted glioblastoma therapy development.

Area of Science:

  • Oncology
  • Genetics
  • Systems Biology

Background:

  • MicroRNAs (miRNAs) are crucial regulators of cellular metabolism.
  • Metabolic reprogramming significantly drives cancer's phenotypic plasticity.
  • Understanding miRNA-metabolism interactions is key for cancer therapy development.

Purpose of the Study:

  • To investigate the impact of differentially expressed miRNAs on metabolism and oncogenic phenotypes in glioblastoma (GBM).
  • To identify specific miRNA targets for regulating GBM's cellular metabolism and oncogenic traits.

Main Methods:

  • Analysis of patient-derived glioblastoma data.
  • Construction and analysis of miRNA-metabolic gene networks using graph network approaches (network diffusion, backbone extraction, centrality measures).
  • Annotation of metabolic processes and cellular phenotypes to identify functional responses.

Main Results:

  • Identification of key miRNAs regulating major metabolic pathways in GBM.
  • Extraction of miRNA-regulated metabolic gene subnetworks linked to specific cellular phenotypes.
  • Prediction of target miRNA combinations for five distinct oncogenic phenotypes in GBM.

Conclusions:

  • The study provides potential miRNA combinations for experimental validation in glioblastoma therapy.
  • The implemented strategies can generate hypotheses for other cancer types and personalized miRNA-based therapies.
  • The approach is extendable to other gene regulatory networks in cancer and genetic diseases.